Skip to main content

Joon Hyung Doh, MD, PhD

Original Contribution
06/28/2011
ABSTRACT: Background. The process of in-stent neointimal hyperplasia (NIH) between drug-eluting stents (DES) and bare metal stents (BMS) might be different. We compared in vivo composition of in-stent NIH between DES and BMS using virtual...
ABSTRACT: Background. The process of in-stent neointimal hyperplasia (NIH) between drug-eluting stents (DES) and bare metal stents (BMS) might be different. We compared in vivo composition of in-stent NIH between DES and BMS using virtual...
ABSTRACT: Background. The...
06/28/2011
Journal of Invasive Cardiology
Original Contribution
09/02/2015
Long-term clinical outcomes of real-world use of fractional flow reserve (FFR) have not been fully evaluated in the era of DES implantation. FFR-measured lesions (n = 1628) were divided according to treatment strategy selected after FFR...
Long-term clinical outcomes of real-world use of fractional flow reserve (FFR) have not been fully evaluated in the era of DES implantation. FFR-measured lesions (n = 1628) were divided according to treatment strategy selected after FFR...
Long-term clinical outcomes of...
09/02/2015
Journal of Invasive Cardiology
Original Contribution
07/30/2015
The prognostic value of poststent fractional flow reserve (FFR) has not been clearly defined in patients with DES implantation. This study evaluates the association between FFR and clinical outcomes after DES implantation with IVUS...
The prognostic value of poststent fractional flow reserve (FFR) has not been clearly defined in patients with DES implantation. This study evaluates the association between FFR and clinical outcomes after DES implantation with IVUS...
The prognostic value of...
07/30/2015
Journal of Invasive Cardiology